ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/20 | 2,003 | 2,008 | 1,939 | 1,972 | -46 | -2.3% | 1,432,600 |
| 2022/10/19 | 2,036 | 2,055 | 2,008 | 2,018 | -12 | -0.6% | 825,300 |
| 2022/10/18 | 2,027 | 2,034 | 1,994 | 2,030 | +14 | +0.7% | 1,094,100 |
| 2022/10/17 | 2,030 | 2,084 | 2,016 | 2,016 | +41 | +2.1% | 2,203,200 |
| 2022/10/14 | 1,900 | 1,984 | 1,897 | 1,975 | +105 | +5.6% | 1,598,800 |
| 2022/10/13 | 1,897 | 1,904 | 1,862 | 1,870 | -27 | -1.4% | 600,800 |
| 2022/10/12 | 1,913 | 1,927 | 1,881 | 1,897 | -13 | -0.7% | 712,500 |
| 2022/10/11 | 1,895 | 1,928 | 1,890 | 1,910 | +6 | +0.3% | 583,800 |
| 2022/10/07 | 1,948 | 1,966 | 1,896 | 1,904 | -42 | -2.2% | 920,600 |
| 2022/10/06 | 1,911 | 1,963 | 1,908 | 1,946 | +31 | +1.6% | 1,105,600 |
| 2022/10/05 | 1,903 | 1,927 | 1,883 | 1,915 | -8 | -0.4% | 791,900 |
| 2022/10/04 | 1,912 | 1,925 | 1,880 | 1,923 | +25 | +1.3% | 873,400 |
| 2022/10/03 | 1,840 | 1,900 | 1,811 | 1,898 | +65 | +3.5% | 965,000 |
| 2022/09/30 | 1,865 | 1,873 | 1,815 | 1,833 | -13 | -0.7% | 732,400 |
| 2022/09/29 | 1,830 | 1,886 | 1,816 | 1,846 | +56 | +3.1% | 1,037,600 |
| 2022/09/28 | 1,795 | 1,863 | 1,782 | 1,790 | +6 | +0.3% | 1,360,700 |
| 2022/09/27 | 1,772 | 1,798 | 1,748 | 1,784 | +22 | +1.2% | 786,100 |
| 2022/09/26 | 1,777 | 1,818 | 1,762 | 1,762 | -47 | -2.6% | 1,564,800 |
| 2022/09/22 | 1,849 | 1,879 | 1,790 | 1,809 | -72 | -3.8% | 2,269,700 |
| 2022/09/21 | 1,888 | 1,891 | 1,846 | 1,881 | -25 | -1.3% | 1,041,200 |
| 2022/09/20 | 1,940 | 1,950 | 1,843 | 1,906 | -33 | -1.7% | 1,788,500 |
| 2022/09/16 | 1,952 | 1,968 | 1,896 | 1,939 | +17 | +0.9% | 1,783,000 |
| 2022/09/15 | 1,926 | 1,954 | 1,910 | 1,922 | +19 | +1% | 1,197,800 |
| 2022/09/14 | 1,843 | 1,919 | 1,841 | 1,903 | +11 | +0.6% | 1,287,900 |
| 2022/09/13 | 1,846 | 1,920 | 1,840 | 1,892 | +44 | +2.4% | 1,543,400 |
| 2022/09/12 | 1,818 | 1,848 | 1,803 | 1,848 | +41 | +2.3% | 1,204,600 |
| 2022/09/09 | 1,707 | 1,816 | 1,696 | 1,807 | +108 | +6.4% | 1,951,400 |
| 2022/09/08 | 1,714 | 1,726 | 1,685 | 1,699 | +14 | +0.8% | 814,800 |
| 2022/09/07 | 1,714 | 1,726 | 1,675 | 1,685 | -30 | -1.7% | 915,800 |
| 2022/09/06 | 1,738 | 1,752 | 1,711 | 1,715 | -23 | -1.3% | 772,200 |
| 2022/09/05 | 1,708 | 1,745 | 1,694 | 1,738 | +25 | +1.5% | 963,400 |
| 2022/09/02 | 1,750 | 1,773 | 1,711 | 1,713 | -27 | -1.6% | 1,083,800 |
| 2022/09/01 | 1,737 | 1,757 | 1,724 | 1,740 | -6 | -0.3% | 686,500 |
| 2022/08/31 | 1,740 | 1,750 | 1,731 | 1,746 | +6 | +0.3% | 466,200 |
| 2022/08/30 | 1,730 | 1,740 | 1,703 | 1,740 | +26 | +1.5% | 830,300 |
| 2022/08/29 | 1,693 | 1,729 | 1,678 | 1,714 | -47 | -2.7% | 1,462,300 |
| 2022/08/26 | 1,742 | 1,795 | 1,738 | 1,761 | +19 | +1.1% | 1,316,800 |
| 2022/08/25 | 1,726 | 1,766 | 1,721 | 1,742 | +69 | +4.1% | 1,818,400 |
| 2022/08/24 | 1,728 | 1,736 | 1,673 | 1,673 | -62 | -3.6% | 1,106,500 |
| 2022/08/23 | 1,718 | 1,741 | 1,702 | 1,735 | -6 | -0.3% | 1,009,600 |
| 2022/08/22 | 1,696 | 1,754 | 1,677 | 1,741 | +27 | +1.6% | 1,832,800 |
| 2022/08/19 | 1,667 | 1,728 | 1,662 | 1,714 | +54 | +3.3% | 1,536,000 |
| 2022/08/18 | 1,632 | 1,665 | 1,625 | 1,660 | +4 | +0.2% | 989,700 |
| 2022/08/17 | 1,624 | 1,674 | 1,619 | 1,656 | +19 | +1.2% | 1,094,000 |
| 2022/08/16 | 1,590 | 1,638 | 1,585 | 1,637 | +35 | +2.2% | 1,313,500 |
| 2022/08/15 | 1,606 | 1,622 | 1,581 | 1,602 | -18 | -1.1% | 1,078,100 |
| 2022/08/12 | 1,624 | 1,654 | 1,566 | 1,620 | +36 | +2.3% | 2,000,000 |
| 2022/08/10 | 1,621 | 1,625 | 1,572 | 1,584 | -75 | -4.5% | 1,438,300 |
| 2022/08/09 | 1,654 | 1,672 | 1,625 | 1,659 | +37 | +2.3% | 1,411,500 |
| 2022/08/08 | 1,593 | 1,641 | 1,588 | 1,622 | +9 | +0.6% | 1,192,000 |
651～
700
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| 栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
